Sectors
BBLG
Bone Biologics Corporation
0.58
2 x 0.41
2 x 0.73
bid
ask
-
0.04
6.18%
2 @ 06:59 PM
0.57 -0.01 (2.03%)
| Ytd | -60.21% | |
| 1y | -73.16% |
0.56
day range
0.59
0.56
52 week range
4.13
| Open | 0.59 | Prev Close | 0.61 | Low | 0.56 | High | 0.59 | Mkt Cap | 1.59M |
| Vol | 89.87K | Avg Vol | 331.13K | EPS | -0.28 | P/E | N/A | Forward P/E | -0.41 |
| Beta | 0.74 | Short Ratio | 0.18 | Inst. Own | 4.59% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 1.04 | 200-d Avg | 1.33 | 1yr Est | 16.75 |
| Income Statement | |||
| Operating Expenses | 808.11K | ||
| Research and Development Expense | 308.75K | ||
| Selling, General and Administrative Expense | 499.36K | ||
| Operating Income | -808.11K | ||
| Net Income | -773.70K | ||
| Net Income Common Stock | -773.70K | ||
| Net Income Common Stock (USD) | -773.70K | ||
| Consolidated Income | -773.70K | ||
| Earnings per Basic Share | -0.43 | ||
| Earnings per Basic Share (USD) | -0.43 | ||
| Earnings per Diluted Share | -0.43 | ||
| Earning Before Interest & Taxes (EBIT) | -773.70K | ||
| Earning Before Interest & Taxes (USD) | -773.70K | ||
| Weighted Average Shares | 1.80M | ||
| Weighted Average Shares Diluted | 1.80M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.03M | ||
| Cash and Equivalents (USD) | 4.03M | ||
| Current Assets | 4.44M | ||
| Total Assets | 4.44M | ||
| Current Liabilities | 512.02K | ||
| Total Liabilities | 512.02K | ||
| Accumulated Retained Earnings (Deficit) | -89.67M | ||
| Shareholders Equity | 3.92M | ||
| Shareholders Equity (USD) | 3.92M | ||
| Trade and Non-Trade Payables | 511.47K | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 20.18K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -498.26K | ||
| Issuance (Purchase) of Equity Shares | 20.18K | ||
| Net Cash Flow from Operations | -518.44K | ||
| Share Based Compensation | 8.25K | ||